Hinge Health: Aiming High with $32 IPO Pricing
Deal News | May 22, 2025 | Top Technology Ventures Ltd
Hinge Health has announced the pricing of its initial public offering (IPO) at $32 per share, which will see the sale of 13,666,000 shares of Class A common stock. Of these, 8,522,528 shares are being sold by Hinge Health itself, and 5,143,472 by existing stockholders, with an option for underwriters to purchase an additional 2,049,900 shares. The IPO is set for trading on the NYSE on May 22, 2025, under the symbol HNGE, and closing a day later. The proceeds from the IPO, a substantial part from Hinge Health's share sales, are earmarked for tax-related obligations tied to the issuance of restricted stock units. Hinge Health is a technology company specializing in AI-driven software for musculoskeletal healthcare, headquartered in San Francisco. Major financial institutions like Morgan Stanley, Barclays, and BofA Securities lead the book-running for this offering.
Sectors
- Healthcare Technology
- Financial Services
Geography
- United States – Hinge Health is headquartered in San Francisco, and the IPO will occur on the New York Stock Exchange.
Industry
- Healthcare Technology – Hinge Health operates in Healthcare Technology, using AI and software for musculoskeletal healthcare solutions.
- Financial Services – The article discusses an Initial Public Offering, involving numerous financial institutions as underwriters.
Financials
- $32.00 per share – The IPO price per share of Hinge Health's Class A common stock.
- 13,666,000 shares – The total number of shares to be sold in the IPO.
- 2,049,900 shares – The additional shares offered to underwriters as an option.
- $437.312 million – The total proceeds from the IPO (calculated as 13,666,000 shares x $32).
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Hinge Health | Target Company | Company | Hinge Health focuses on AI-driven software for musculoskeletal healthcare, aiming to improve member outcomes and reduce costs. |
| Top Technology Ventures Ltd. | PE Firm | Company | The private equity firm backing Hinge Health. |
| Morgan Stanley, Barclays, BofA Securities | Lead Book-running Managers | Company | Major financial institutions managing the IPO process. |
| Selling Stockholders | Selling Company | Company | The existing shareholders selling part of their holdings in the IPO. |
| Securities and Exchange Commission | Regulatory Body | Government | Government agency that oversees securities transactions in the United States. |